Danaher Corporation against Moderna, Inc. — live side-by-side technical comparison.
Prices as of 2026-10-09T20:03:23+00:00 UTC · updates daily
MRNA leads 5 of the 5 windows we measure — over 1 month DHR is +7.3% and MRNA +65.9%; over year to date DHR is -4.0% and MRNA +663.0%. The DHR/MRNA price ratio stands at 0.9769, below its 50-day average of 1.8577, and below the 200-day average of 3.5423. A ratio above its own average means DHR is gaining on MRNA; on this reading the recent edge belongs to MRNA.
| DHR | MRNA | |
|---|---|---|
| Price | $219.81 | $225.00 |
| 1 day | +1.1% | +14.2%lead |
| 5 days | +2.7% | +18.4%lead |
| 1 month | +7.3% | +65.9%lead |
| 6 months | +13.9% | +338.8%lead |
| Year to date | -4.0% | +663.0%lead |
| 52-week position | 72% of range | 100% of range |
| 52-week range | $160.93–$242.80 | $22.28–$225.00 |
| vs 50-day average | above $211.05 | above $138.26 |
| vs 200-day average | above $201.44 | above $72.63 |
| RSI (14) | 54 | 72 |
| Next earnings | 2026-10-21 | 2026-11-05 |
DHR trades at $219.81, above its 50-day average of $211.05, and above the 200-day at $201.44. It sits at 72% of its 52-week range ($160.93–$242.80); 14-day RSI is 54, in neutral territory; an average session moves it about 3.0%. For levels, the first level overhead is $225.00 (2.4% away) and the first support below is $211.05 (4.0% down). On the checklist the page runs for every asset, 4 of 6 checks read bullish — the lean is bullish.
MRNA trades at $225.00, above its 50-day average of $138.26, and above the 200-day at $72.63. It sits at 100% of its 52-week range ($22.28–$225.00); 14-day RSI is 72, in overbought territory; an average session moves it about 7.1%. For levels, the first level overhead is $250.00 (11.1% away) and the first support below is $200.00 (11.1% down). On the checklist the page runs for every asset, 5 of 6 checks read bullish — the lean is bullish.
MRNA is the more volatile of the two — an average session moves it 7.1% against 3.0% for DHR, so an identical position size carries roughly 2.4× the daily risk.
The comparison turns on those levels: DHR clearing $225.00 or losing $211.05; MRNA clearing $250.00 or losing $200.00. Until one of them gives way, the relative reading above stands.